LCC Reviewers Required

The ‘Let’s Communicate Cancer’ working group have a great opportunity for pharmacists to become involved in the review of the ‘Let’s communicate cancer’ training modules.

 

‘Let’s communicate cancer’ is an extensive resource for all health professionals on many aspects of cancer care. The resource includes information on cancer prevention, diagnosis, treatments, and how to better support patients undergoing cancer treatment. Of the five training modules, four will need to be reviewed in the current update:

 

  • Module 1: Early diagnosis and prevention
  • Module 2: What is cancer
  • Module 3: Treatment of cancer
  • Module 4: Supporting your patients with cancer

 

Who are we looking for?

 

For the update, we are looking for a number of experienced pharmacists to review the eLearning content which includes PowerPoint presentations, quizzes, PDFs and videos. If you have a minimum of 3 years’ experience practicing in oncology, or alternatively, if you are a community pharmacist with an interest in oncology we would love to hear from you.

 

How to apply?

 

If you would like to get involved please send us a brief statement (roughly 300 words) of the skills and experience you have which would be beneficial in the review of the modules. Please also include your current role and place of work.

Applications should be sent to [email protected]. Please note, applications will close on 29th March 2024 and we will let candidates know the outcome by 22nd April 2024.

 

Thank you!

We understand everyone is under increased pressure at the moment and the reviewer will be remunerated for their valuable time. We aim to have the review completed by the end of May.

Thank you for considering this opportunity and we look forward to hearing from you!

 

Best wishes,

Jackie Lewis and Jennifer McClintick

Latest News

By BOPA Committee on 3rd May 2025

Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology Podcasts worldwide

The BOPA podcast team (Michal Sladkowski, Chiara Creed and Eleanor Meerstadt) are thrilled to share that the Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology…

Read article
By BOPA Education & Training Subcommittee on 3rd May 2025

NEW eLearning module for Myeloma now live

Dear BOPA members,   The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…

Read article
By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article